AlphaFold predicted structure
ATOH1 · Q92858

Mean pLDDT
59.2/ 100
Low
354 residues
Confidence breakdown
- Very high(≥ 90)16%
- Confident(70–90)9%
- Low(50–70)31%
- Very low(< 50)45%
AlphaFold (Jumper et al., 2021) · CC BY 4.0
atonal bHLH transcription factor 1
Annotations refreshed 9 hours ago.
Moderate Evidence (Amber)
Ataxia and cerebellar anomalies - narrow panel
BOTH monoallelic and biallelic (but BIALLELIC mutations cause a more SEVERE disease form), autosomal or pseudoautosomalIntellectual disability
BIALLELIC, autosomal or pseudoautosomalMonogenic hearing loss
BOTH monoallelic and biallelic (but BIALLELIC mutations cause a more SEVERE disease form), autosomal or pseudoautosomalhearing loss, autosomal dominant 89
aortic disorder
cardiomyopathy
pontocerebellar hypoplasia
injury
colorectal cancer
vascular disorder
prostate carcinoma
colorectal adenoma
intelligence
Score is the Open Targets composite evidence score (0-1). Higher = stronger gene-disease association.
Transcription factor ATOH1
Transcriptional regulator. Activates E box-dependent transcription in collaboration with TCF3/E47, but the activity is completely antagonized by the negative regulator of neurogenesis HES1. Plays a role in the differentiation of subsets of neural cells by activating E box-dependent transcription (By similarity)
ATOH1 · Q92858

Mean pLDDT
59.2/ 100
Low
354 residues
Confidence breakdown
AlphaFold (Jumper et al., 2021) · CC BY 4.0